Consumer
The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.
The feature will be available via new iOS and watchOS updates, one year after the U.S. International Trade Commission banned Apple from selling its Series 9, Series 10 and Ultra 2 watches.
The company will use the funds to expand its technology offerings and nationwide partnerships.
Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients when action is advised.
The company also disclosed that it reached an agreement with most holders of its Series A and Series B warrants to convert those warrants into common stock.
The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.
The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.
Synchron announced an ALS patient has become the first person to control an iPad using only his thoughts, thanks to a brain-computer interface and Apple’s BCI protocol.
The company is adding 4,200 clinics to its provider network and enabling cost-sharing as well as direct claims payment to providers and clinicians.
The EU says makers and distributors of health-related app stores or applications will now be considered medical device makers and must adhere to associated regulations.